Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 110
Selected: 0
NCT IDTitle
NCT00385606Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
NCT01644825Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer
NCT01005641ELBA: Exemestane and Lapatinib in Advanced Breast Cancer
NCT01593488Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children
NCT05733793Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients.
NCT04425239Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer
NCT06887244Effectiveness of Nurse Tele-consultation on the Quality of Elective Colonoscopy, Procedure-related Anxiety, and Financial Toxicity
NCT02624128Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
NCT06218511A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)
NCT06905145Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
NCT01359956Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma
NCT05817227Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
NCT00401635END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin
NCT01405573Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma
NCT03203005IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients
NCT06884878Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA)
NCT00401609G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients
NCT02619435Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer
NCT00431704VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer
NCT02035683PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
NCT01405586MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer
NCT00540800BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer
NCT04397601Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer
NCT01898104Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer
NCT06905262Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
NCT03891485Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy
NCT03410784Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer
NCT01801904A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer
NCT00401674MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer
NCT06894823Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)
NCT03503786Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer
NCT00403429MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer
NCT06893861Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
NCT01755182Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors
NCT00526643CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients
NCT00526396STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
NCT04893785A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)
NCT04854213PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)
NCT01706120Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab
NCT00415779ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer
NCT07213570STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer
NCT04122911Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas
NCT05733806Study on Gynecological Rare Cancers
NCT06880523STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
NCT05818020Multidisciplinary Integrated Platform for a Technological Innvovative Approach to Oncotherapies
NCT04595032MAnagement of METastatic Disease in Campania (MAMETIC)
NCT01481545Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer
NCT04129281Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma
NCT01651026Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer
NCT07027046Application of da Vinci SP for Endometrial Cancer Surgical Staging